These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

395 related articles for article (PubMed ID: 12468575)

  • 1. Hyperaldosteronism among black and white subjects with resistant hypertension.
    Calhoun DA; Nishizaka MK; Zaman MA; Thakkar RB; Weissmann P
    Hypertension; 2002 Dec; 40(6):892-6. PubMed ID: 12468575
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Validity of plasma aldosterone-to-renin activity ratio in African American and white subjects with resistant hypertension.
    Nishizaka MK; Pratt-Ubunama M; Zaman MA; Cofield S; Calhoun DA
    Am J Hypertens; 2005 Jun; 18(6):805-12. PubMed ID: 15925740
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prevalence of primary hyperaldosteronism assessed by aldosterone/renin ratio and spironolactone testing.
    Hood S; Cannon J; Foo R; Brown M
    Clin Med (Lond); 2005; 5(1):55-60. PubMed ID: 15745200
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Normokalemic hyperaldosteronism in patients with resistant hypertension.
    Benchetrit S; Bernheim J; Podjarny E
    Isr Med Assoc J; 2002 Jan; 4(1):17-20. PubMed ID: 11802302
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Does the ratio of serum aldosterone to plasma renin activity predict the efficacy of diuretics in hypertension? Results of RENALDO.
    Parthasarathy HK; Alhashmi K; McMahon AD; Struthers AD; McInnes GT; Ford I; Connell JM; MacDonald TM
    J Hypertens; 2010 Jan; 28(1):170-7. PubMed ID: 20009770
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Impaired endothelium-dependent flow-mediated vasodilation in hypertensive subjects with hyperaldosteronism.
    Nishizaka MK; Zaman MA; Green SA; Renfroe KY; Calhoun DA
    Circulation; 2004 Jun; 109(23):2857-61. PubMed ID: 15173035
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hyperaldosteronism and hypertension: ethnic differences.
    Grim CE; Cowley AW; Hamet P; Gaudet D; Kaldunski ML; Kotchen JM; Krishnaswami S; Pausova Z; Roman R; Tremblay J; Kotchen TA
    Hypertension; 2005 Apr; 45(4):766-72. PubMed ID: 15699471
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Lessons from Africa: the importance of measuring plasma renin and aldosterone in resistant hypertension.
    Spence JD
    Can J Cardiol; 2012 May; 28(3):254-7. PubMed ID: 22289470
    [No Abstract]   [Full Text] [Related]  

  • 9. [Rectal electrical potential difference and plasma aldosterone in hyperaldosteronism and low-, normal- and high-renin hypertension].
    Skrabal F; Mauser R
    Wien Klin Wochenschr; 1976 Dec; 88(23):777-81. PubMed ID: 1014711
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prevalence of primary hyperaldosteronism in resistant hypertension: a retrospective observational study.
    Douma S; Petidis K; Doumas M; Papaefthimiou P; Triantafyllou A; Kartali N; Papadopoulos N; Vogiatzis K; Zamboulis C
    Lancet; 2008 Jun; 371(9628):1921-6. PubMed ID: 18539224
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Primary hyperaldosteronism: a missed diagnosis in 'essential hypertensives'?
    Brown MA; Cramp HA; Zammit VC; Whitworth JA
    Aust N Z J Med; 1996 Aug; 26(4):533-8. PubMed ID: 8873937
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Screening for primary aldosteronism: implications of an increased plasma aldosterone/renin ratio.
    Schwartz GL; Chapman AB; Boerwinkle E; Kisabeth RM; Turner ST
    Clin Chem; 2002 Nov; 48(11):1919-23. PubMed ID: 12406976
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Rapid reversal of left ventricular hypertrophy and intracardiac volume overload in patients with resistant hypertension and hyperaldosteronism: a prospective clinical study.
    Gaddam K; Corros C; Pimenta E; Ahmed M; Denney T; Aban I; Inusah S; Gupta H; Lloyd SG; Oparil S; Husain A; Dell'Italia LJ; Calhoun DA
    Hypertension; 2010 May; 55(5):1137-42. PubMed ID: 20351345
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Studies on essential hypertension with suppressed plasma renin activity: sodium excretion pattern on salt restriction and effects of spironolactone on blood pressure and plasma renin activity.
    Uchida K; Morimoto S; Takeda R; Murakami M
    Jpn Circ J; 1972 Dec; 36(12):1301-11. PubMed ID: 4679217
    [No Abstract]   [Full Text] [Related]  

  • 15. Validity of the aldosterone-renin ratio used to screen for primary aldosteronism.
    Montori VM; Schwartz GL; Chapman AB; Boerwinkle E; Turner ST
    Mayo Clin Proc; 2001 Sep; 76(9):877-82. PubMed ID: 11560297
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The spironolactone, amiloride, losartan, and thiazide (SALT) double-blind crossover trial in patients with low-renin hypertension and elevated aldosterone-renin ratio.
    Hood SJ; Taylor KP; Ashby MJ; Brown MJ
    Circulation; 2007 Jul; 116(3):268-75. PubMed ID: 17606839
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Conn syndrome as cause of stubborn hypertension. Which hypertensives should you screen?].
    Reincke M
    MMW Fortschr Med; 2003 Feb; 145(9):37-40. PubMed ID: 12666528
    [No Abstract]   [Full Text] [Related]  

  • 18. Aldosterone excretion among subjects with resistant hypertension and symptoms of sleep apnea.
    Calhoun DA; Nishizaka MK; Zaman MA; Harding SM
    Chest; 2004 Jan; 125(1):112-7. PubMed ID: 14718429
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The role of aldosterone antagonists in the management of resistant hypertension.
    Nishizaka MK; Calhoun DA
    Curr Hypertens Rep; 2005 Oct; 7(5):343-7. PubMed ID: 16157075
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Detection of primary aldosteronism by the 6-hour integrated aldosterone/renin ratio.
    Zadik Z; Levin PA; Hamilton BP; Kowarski AA
    Hypertension; 1986 Apr; 8(4):285-9. PubMed ID: 3514448
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.